TNF and musculoskeletal system disorder: Concerning the interaction with seed genes, we confirmed that interleukin/protein kinase/TNF-alpha inhibitors, drugs for musculoskeletal system disorders, TUDCA, immunosuppressants, antirheumatic agents, and simvastatin and atorvastatin were among the potential drug classes, regardless of PBC stage.